BioNote Stock

BioNote Diluted EPS

The Diluted Earnings per Share of BioNote (377740.KS) as of Sep 3, 2026 is 542.00 KRW. In the previous year, Diluted Earnings per Share was -200.99 KRW — a change of -369.66% (higher).

Diluted EPS

542.00KRW

YoY

-369.66%

Last updated:

Diluted Earnings per Share of BioNote is 2026 542.00 KRW. Diluted Earnings per Share of BioNote was 2025 -200.99 KRW. It decreases by -369.66% higher compared to the previous year.

The BioNote Diluted EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Diluted EPS
Date
Diluted EPS
Jan 1, 2019
202.33 KRW
Jan 1, 2020
5,185.02 KRW
Jan 1, 2021
7,221.67 KRW
Jan 1, 2022
3,021.30 KRW
Jan 1, 2023
-200.99 KRW
Jan 1, 2024
542.00 KRW
The BioNote Diluted EPS history
YEARDiluted EPSYoY
542.00KRW-369.66%
-200.99KRW-106.65%
3,021.30KRW-58.16%
7,221.67KRW+39.28%
5,185.02KRW+2,462.62%
202.33KRW—
Access this data via the Eulerpool API
Get Free API Key

BioNote Stock analysis

What does BioNote do? BioNote is one of the most popular companies on Eulerpool.

Frequently Asked Questions about BioNote stock

Diluted Earnings per Share of BioNote is 542.00 KRW in 2026.

Diluted Earnings per Share of BioNote changed from -200.99 KRW to 542.00 KRW, representing a -369.66% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Diluted Earnings per Share BioNote since 2006 – with annual values, charts, and detailed analysis.

Diluted EPS accounts for all potential shares from options, warrants, and convertible securities. It provides a more conservative per-share earnings measure.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — BioNote

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — BioNote